After 6 months of basal insulin analogue treatment, the incidence of symptomatic hypoglycemia was substantially lower, affecting 71 subjects (15.4%; p < 0.001 vs. 6 months before insulin analogue treatment). Here, INS is linked to Hypoglycemia.